A three-layer co-extruded film for pharmaceutical blister packs, its preparation method and application

By adding silane-modified cyclodextrin metal-organic framework materials to the PP/COC/PP system, the problems of insufficient water and oxygen barrier properties and migration and precipitation of inorganic hygroscopic materials in pharmaceutical blister materials have been solved, thus achieving pharmaceutical blister materials with high efficiency in water and oxygen barrier and long service life.

CN123104197APending Publication Date: 2026-11-17SUZHOU OGILVY MATERIAL TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611620257.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-10-20
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing pharmaceutical blister materials suffer from insufficient water and oxygen barrier properties and the tendency for inorganic moisture-absorbing materials to migrate and leach out, making it difficult to meet the requirements for high barrier properties and long lifespan.

Method used

By adding silane-modified cyclodextrin metal-organic framework materials to the PP/COC/PP system, the uniform dispersion and stable binding of MOF particles can be achieved through chemical bond anchoring and cross-linking network, forming a three-layer co-extruded film.

Benefits of technology

The prepared three-layer co-extruded film for pharmaceutical blister packs has high-efficiency water vapor and oxygen barrier properties, no migration or precipitation, long service life, and is suitable for pharmaceutical packaging.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123104197A_ABST
    Figure CN123104197A_ABST
Patent Text Reader

Abstract

This invention discloses a three-layer co-extruded film for pharmaceutical blister packs, comprising a functional layer A, a functional layer B, and a functional layer C. Functional layer B comprises a cyclic olefin copolymer and a silane-modified cyclodextrin metal-organic framework material. Functional layers A and C each comprise polypropylene and maleic anhydride. By adding a silane-modified cyclodextrin metal-organic framework material to the existing PP / COC / PP system, the migration and precipitation problem of existing inorganic hygroscopic materials is solved. Simultaneously, the resulting three-layer co-extruded film for pharmaceutical blister packs exhibits high barrier properties against both water vapor and oxygen.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of pharmaceutical packaging materials technology, specifically to a three-layer co-extruded film for pharmaceutical blister packs, its preparation method, and its application. Background Technology

[0002] Pharmaceutical blister packaging materials are typically thin film materials used to protect drugs from moisture, light, or other factors that could reduce their efficacy or degrade their properties, and to fix the drug in place. Their application began to flourish in Europe in the 1930s, and solid dosage forms (tablets, capsules) gradually developed into one of the most important packaging methods. This packaging form provides highly effective protection for drugs: such as moisture protection, oxygen protection, contamination protection, visibility, tamper protection, and extended shelf life, thus becoming the standard packaging form in the global pharmaceutical industry.

[0003] Pharmaceutical blister packaging material was first proposed in the 1930s as single-layer polyvinyl chloride (PVC): it has a simple thermoforming process, low cost, and good transparency, but its water vapor permeability (WVTR) is relatively high, approximately 3.0 g / m³. 2 The film exhibits poor moisture barrier properties, measured at 38 ℃ / 90% RH per day. Subsequently, between the 1990s and 2015, films with a PVC / polyvinylidene chloride (PVDC) bilayer high-barrier system were gradually developed. PVDC is a highly crystalline polymer with high oxygen barrier properties, but it has drawbacks such as environmental restrictions (due to chlorine-containing materials), a narrow processing temperature window, and difficulties in recycling. Meanwhile, to meet the packaging requirements of highly sensitive drugs, a PVC / Al / nylon (PA) trilayer composite film emerged, offering near-zero water permeability, but its disadvantages include opacity, high cost, and low molding yield.

[0004] With increasingly stringent environmental regulations (such as the EU REACH), PVC is facing imminent phase-out. Consequently, companies like TOPAS, Zeon, and Amcor have developed multilayer barrier films made of polypropylene (PP) / cyclic olefin copolymers (COC), typically with a PP / COC / PP structure. COC is an amorphous polymer obtained by chain copolymerization or ring-opening polymerization of cyclic monomers (such as norbornene or tetracyclododecene) with ethylene, followed by hydrogenation. COC is a high-purity, low-extractant polymer, free of halogens and bisphenol A; it possesses high modulus, low moisture absorption, high transparency, high thermal stability, and can be sterilized at high temperatures, meeting pharmaceutical moisture barrier performance standards, thus finding wide application in the medical and optical equipment fields. For example: very high water vapor barrier properties (approximately 10 times that of PVC and more than twice that of PVDC); good chemical resistance; good chemical resistance and barrier properties against other solvents (such as alcohol); and very high resistance to acid and alkali corrosion compared to polypropylene and polyethylene; excellent biocompatibility; high dimensional stability; and compliance with USP VI and FDA regulations, suitable for radiation and ethylene oxide sterilization processes; low COC density (1.02 g / cm³). 3 PVC content is 1.4 g / cm³. 3 This means that less material is needed, thus saving costs.

[0005] In summary, while the aforementioned materials exhibit excellent water vapor barrier properties, they can be categorized as purely "passive barrier" materials. Therefore, some researchers have used inorganic hygroscopic fillers (such as silica gel, calcium chloride, and molecular sieves) to impart "active hygroscopic" functionality to these materials through physical or chemical hygroscopic absorption. Although this method is technologically mature, low-cost, and possesses strong hygroscopic capacity (e.g., CaCl2), it suffers from several drawbacks, such as irreversible hygroscopic absorption (CaCl2), easy migration / precipitation, and impact on transparency. Considering the current situation and all existing technologies, there is an urgent need to develop a pharmaceutical blister film material that simultaneously possesses high water and oxygen barrier properties and prevents migration and precipitation.

[0006] Metal-organic frameworks (MOFs) are porous crystalline materials composed of organic linkers, transition metals, and lanthanide clusters, forming 1D, 2D, and 3D lattices through coordination bonds. MOFs consist of two main components: inorganic metal clusters (secondary structural units) and linkers (organic molecules). MOFs possess numerous properties such as diverse modifiability, high surface area, ultra-high porosity, and thermal stability, making them highly promising for applications in gas storage and separation, catalysis, chemical sensors, pharmaceuticals, and biomedical imaging. However, the molecular composition of traditional MOFs often makes them incompatible with conventional polymers, and they also fail to meet the safety requirements for human use in pharmaceutical blister materials, thus limiting their development in this field.

[0007] Cyclodextrins (CDs), as precursors to metal-organic frameworks (MOFs) derived from bio-based starch, naturally endow CD-MOFs with non-toxic and environmentally friendly properties, thus meeting the requirements from a biomedical perspective. Specifically, CDs are cyclic oligosaccharides obtained through the enzymatic reaction of starch, composed of six, seven, or eight pyranose units, existing in three forms: a, b, and g. CDs can combine with many inorganic or organic molecules to form host-guest CD-MOF compounds, such as coordinating with alkaline earth metals to create novel metal-organic frameworks (i.e., CD-MOFs). Based on the unique structural characteristics of CDs molecules, they can form a hydrophobic inner cavity and a hydrophilic outer surface. The coordination framework of CD-MOFs possesses additional advantages such as high specific surface area, novel porosity, edibility, and meeting the requirements for human pharmaceutical safety. Research on CD-MOFs has demonstrated their enormous application potential in separation, sensing, and pharmaceutical delivery. Smaldone et al. successfully prepared cubic CD-MOF-K in an aqueous medium under normal temperature and pressure conditions for the first time: CD-MOF-K was synthesized from the structural units of food-grade CDs with a salt (potassium chloride), and it was also shown that other CD-MOFs could be synthesized from Na+. + and Fe 3+ Salts are readily available, and these salts have enriched the variety of CD-MOFs. These results demonstrate that the diversity and controllability of CD-MOFs can meet the requirements of various applications. The unique properties of CD-MOFs demonstrated in this study include the high specific surface area of ​​their coordination framework, novel porosity, and the added advantage of being edible.

[0008] Due to its larger pore size (α-CD approximately 5 Å < β-CD approximately 6.5 Å < γ-CD approximately 7.5~8.5 Å) and highly hydrophilic pore environment, γ-CD-MOF can form stable water clusters. Compared with α- and β-CD-MOF, it can induce water molecules to form hydrogen bond networks and undergo synergistic adsorption under certain relative humidity, exhibiting obvious step adsorption behavior. It shows controllable adsorption response behavior at a certain humidity threshold. When the humidity decreases, water molecules bound by physical adsorption and hydrogen bonding in the framework can achieve reversible desorption (Structure and thermodynamics of water adsorption in NU-1500-Cr, Communications Chemistry, 6, 70, 2023; Metal-organicframeworks for water vapor adsorption, Chem, 2024; Two-stage MOF-coated heatexchanger for efficient humidity control under wide humidity range, EnergyConversion and Management, 348, 2026, 120726). In addition, by adjusting the metal nodes (such as adjustable K) + Na + The adsorption behavior can be designed by considering the nodes and pore chemical environment (Unravelling the Water Adsorption Mechanism in Hierarchical MOFs: Insights from In Situ Positron Annihilation Lifetime Studies, ACS Appl Mater Interfaces. 2023; 15(41):48264–48276). γ-CD-MOFs can stably cycle adsorption-desorption-adsorption of water molecules in the air under low energy consumption conditions. First, the adsorption of water by γ-CD-MOFs exists through the synergistic effect of hydrogen bonds, weak coordination, and physisorption; during the desorption process: when the humidity in the air decreases, the equilibrium is broken, the hydrogen bond network breaks, the synergistic effect of weak coordination and physisorption disappears, and water molecules are released; when the humidity increases, the synergistic effect of hydrogen bonds, weak coordination, and physisorption is formed, and the adsorption of water begins again.

[0009] However, MOFs also face many application challenges that need to be addressed, such as (1) the thermal stability of MOFs, i.e., their ability to maintain crystal structure; and (2) their compatibility with PP / COC. MOFs are polar particles, while PP and COC are non-polar materials. Direct mixing can easily lead to agglomeration, which can also cause migration and precipitation. However, there are still many problems with their application in pharmaceutical blister materials, such as poor compatibility with the matrix (e.g., polyolefins), poor processing stability, and easy agglomeration. Summary of the Invention

[0010] To address the aforementioned technical problems, this invention provides a three-layer co-extruded film for pharmaceutical blister packs. By adding silane-modified cyclodextrin metal-organic framework materials to the existing PP / COC / PP system, the migration and precipitation problems of existing inorganic hygroscopic materials are solved. At the same time, the resulting three-layer co-extruded film for pharmaceutical blister packs has both high barrier properties against water vapor and oxygen.

[0011] A three-layer co-extruded film for pharmaceutical blister packs includes a functional layer A, a functional layer B, and a functional layer C. The functional layer B comprises a cyclic olefin copolymer and a silane-modified cyclodextrin metal-organic framework material, and the functional layers A and C each comprise polypropylene and maleic anhydride.

[0012] In this invention, by adding silane-modified cyclodextrin metal-organic framework (MOF) materials to the existing PP / COC / PP system, on the one hand, silane segments are chemically anchored to the surface of the MOF material, with their terminal organic functional groups extending outward. This significantly reduces the surface energy of the MOF particles, allowing them to form deep entanglement and physical interpenetration with the COC molecular chains during forced dispersion in the COC matrix during mixing, achieving uniform and stable dispersion. More importantly, under the high-temperature shear conditions of three-layer co-extrusion, the reactive groups on the silane segments undergo in-situ chemical bonding with maleic anhydride grafted onto the polypropylene, generating a cross-linked network at the interface between the COC and PP layers. This transforms physical interlayer bonding into chemical bonding, fundamentally inhibiting interlayer delamination and the migration and precipitation of MOF fillers. Simultaneously, the microporous structure of the cyclodextrin MOF material's barrier effect on gas molecules, combined with the increased tortuosity of the gas permeation path due to the cross-linked network, synergistically endows the composite film with excellent and durable dual high barrier properties against water vapor and oxygen.

[0013] Compared to existing traditional moisture-absorbing materials such as CaCl2, the addition of silane-modified cyclodextrin metal-organic framework materials eliminates migration and precipitation issues, resulting in a significantly longer service life for pharmaceutical packaging materials (from 12 to 18 months). Furthermore, it exhibits strong interlayer adhesion and does not delaminate. Therefore, the three-layer co-extruded film for pharmaceutical blister packs prepared in this invention combines high barrier properties with no migration or precipitation, demonstrating significant engineering value and promising industrial application prospects for improving pharmaceutical blister pack materials.

[0014] In this invention, the thin film may also be a combination of multiple functional layers A and C.

[0015] Preferably, the silane-modified cyclodextrin metal-organic framework material is obtained by sequentially modifying γ-cyclodextrin (γ-CD) with potassium hydroxide, methanol, and aminopropyltriethoxysilane, and has the structure shown in formula (I):

[0016] Equation (Ⅰ).

[0017] In this invention, potassium ions (K+) are first provided simultaneously via KOH. + As a metal coordination center, it provides a basic environment that promotes the deprotonation of hydroxyl groups on the γ-CD molecule, and interacts with K. + Coordination self-assembly forms metal-organic framework crystals with long-range ordered microporous structures, K + With a larger ionic radius and suitable coordination strength, it can form a stable water cluster structure with water molecules in the γ-CD cavity, giving the material a humidity threshold-responsive controllable characteristic. When the humidity decreases, water molecules bound in the framework through physical adsorption and hydrogen bonding can be reversibly desorbed.

[0018] Secondly, γ-CD-MOF-K is removed by solvent displacement after methanol activation treatment. + The residual mother liquor, unreacted raw materials, and weakly bound water molecules within the pores allow the micropores of the MOF to fully open, exposing a large number of active hydroxyl sites and K+. + Coordination unsaturated sites. The activated framework has a higher specific surface area and pore volume, providing more accessible chemical anchors for subsequent silane modification, while ensuring the efficient and reversible nature of the water cluster adsorption-desorption cycle.

[0019] Finally, after modification with aminopropyltriethoxysilane, the ethoxy group (-OCH2CH3) of the silane molecule hydrolyzes under aqueous or heating conditions to generate a silanol group (Si-OH), which then reacts with γ-CD-MOF-K + The hydroxyl groups on the surface undergo a condensation reaction to form stable Si-O-MOF covalent bonds, which anchor the silane to the MOF crystal surface in the form of chemical bonds. This can buffer the impact of repeated adsorption and desorption of water molecules on the crystal skeleton under high humidity conditions to a certain extent, and suppress the structural fatigue caused by the expansion and contraction of water clusters, thereby ensuring the long-term stability of the material's structural integrity and barrier performance during long-term use.

[0020] Preferably, in the B functional layer, the mass ratio of the cyclic olefin copolymer to the silane-modified cyclodextrin metal-organic framework material is 50~90:1~25.

[0021] Preferably, the structure of the cyclic olefin copolymer is as follows: , Where m is 390~480, n is 280~460, and the number-average molecular weight (Mn) is 40000~55000 g / mol.

[0022] More preferably, the melt index of the cyclic olefin copolymer is 6-12 cm⁻¹. 3 / 10min.

[0023] Preferably, the melt index of the polypropylene is 6~8 g / 10min.

[0024] In this invention, commercially available polypropylene is used, which is obtained by addition polymerization of propylene monomers and has a number average molecular weight of 40,000 to 55,000 g / mol.

[0025] In subsequent co-extrusion molding processes, if the interlayer viscosity difference is too large, the low-viscosity melt will tend to coat the high-viscosity melt and flow towards the high-shear zone, resulting in unstable flow at the co-extrusion interface and affecting the uniformity of layer thickness and interfacial adhesion strength. Therefore, in this invention, by limiting the melt index of the cyclic olefin copolymer and polypropylene, the melt viscosity of the two is ensured to be similar, improving melt extrusionability and compatibility, and also preventing thermal degradation of the material during processing. This ensures the stability of the co-extrusion process and yields a co-extruded film material with good interlayer bonding.

[0026] Preferably, the A and C functional layers further comprise azobisisobutyronitrile, and the mass ratio of polypropylene, maleic anhydride and azobisisobutyronitrile is 50~90:2~20:2~8.

[0027] In this invention, PP serves as the mechanical support layer and heat-sealing layer of the blister material, endowing the film with excellent mechanical strength, heat-sealing performance, and chemical stability. MAH, as a polar grafting monomer, introduces further reactive polar anchors into the nonpolar PP backbone through the high reactivity of its anhydride groups, providing a molecular basis for subsequent chemical bonding with amino groups on the surface of silane-modified cyclodextrin metal-organic framework materials. AIBN, as a thermally decomposable free radical initiator, uniformly decomposes at the melt processing temperature to generate free radicals, efficiently abstracting tertiary hydrogen atoms from the PP chain to generate macromolecular free radicals, thereby initiating the grafting polymerization of MAH on the PP backbone. Furthermore, its moderate decomposition rate and few side reactions ensure grafting efficiency while maximally suppressing β-fracture degradation of the PP chain, maintaining the integrity of the matrix molecular weight. The synergistic effect of these three components ultimately leads to the efficient introduction of anhydride functional groups into the PP molecular chain, facilitating the in-situ generation of a PP-g-MA-silane-CD-MOF-K crosslinked network during three-layer co-extrusion.

[0028] Preferably, the total thickness of the three-layer co-extruded film for pharmaceutical blister packs is 200~700 μm, wherein the thickness of functional layers A and C is 50~100 μm, and the thickness of functional layer B is 100~500 μm.

[0029] The present invention also provides a method for preparing the above-mentioned three-layer co-extruded film for pharmaceutical blister packs, comprising the following steps: (1) Prepare silane-modified cyclodextrin metal-organic framework material, add cycloolefin copolymer, mix evenly, and obtain B functional layer masterbatch; (2) Polypropylene, maleic anhydride and azobisisobutyronitrile are mixed to prepare A functional layer masterbatch and C functional layer masterbatch. (3) Following the order of functional layer A, functional layer B, and functional layer C, the masterbatch obtained in steps (1) and (2) is processed by a three-layer melt co-extrusion molding method to obtain a three-layer co-extruded film for pharmaceutical blister packs.

[0030] Preferably, in step (3), the melt co-extrusion temperature of functional layer A and functional layer C is 180~240 ℃, and the melt co-extrusion temperature of functional layer B is 200~240 ℃.

[0031] Preferably, in step (3), the setting temperature of the co-extrusion molding is 70~90 ℃.

[0032] The present invention also provides the application of the above-mentioned three-layer co-extruded film for pharmaceutical blister packs in the preparation of pharmaceutical blister pack films.

[0033] Compared with the prior art, the beneficial effects of the present invention are as follows: The pharmaceutical blister pack three-layer co-extruded film prepared by this invention improves the problem of inorganic hygroscopic materials such as calcium chloride precipitating out in the existing PP / COC / PP system by adding a silane-modified cyclodextrin metal-organic framework material. Simultaneously, the prepared pharmaceutical blister pack three-layer co-extruded film also possesses active and controllable moisture absorption and high water and oxygen barrier properties (water vapor barrier rate 0.10~0.62 g / m³). 2 / d, oxygen barrier rate 41~120 cm 3 / m 2 / d) and strong interlayer adhesion. Attached Figure Description

[0034] Figures 1-3 The following are, in order, the preparation route, infrared spectrum, and thermogravimetric analysis of the silane-modified cyclodextrin metal-organic framework material obtained in this invention.

[0035] Figure 4 This is a schematic diagram of the structure of the three-layer co-extruded film for pharmaceutical blister packs prepared in Example 1 of the present invention, wherein A is functional layer A, B is functional layer B, and C is functional layer C. Detailed Implementation

[0036] The present invention will be further described in detail below with reference to the embodiments, but the implementation of the present invention is not limited to the following embodiments.

[0037] All raw materials used in this invention are commercially available. Polypropylene was purchased from Borealis: Bormed HD800CF, Bormed RD834CF, Bormed RD808CF, Bormed RD804CF, and Bormed TD109CF. Cycloolefin copolymers were purchased from Daicel: TOPAS@COC 9506F-500, TOPAS@7010F-600, TOPAS@8007F-04, TOPAS@5013F-04, TOPAS@9506F-500, and TOPAS@8007F-600. γ-Cyclodextrin, potassium hydroxide, methanol, aminopropyltriethoxysilane, and maleic anhydride were commercially available.

[0038] The multi-layer co-extrusion production line equipment adopts the Extrusionline BREYER OptiFlex production line provided by Maschinenfabrik, BREYER GmbH, Germany. The film production equipment for co-extruded films includes: an extruder with a screw diameter (D) of 60 mm and a length of 33D; a melt pump; a crosshead; a flat die with a width of 450 mm; a three-roll calender with horizontally arranged rolls, the third roll rotating approximately 45° relative to the horizontal position; a roller conveyor; a thickness gauge; a device for applying protective film to both sides; a take-off device; and a winding machine.

[0039] Example 1 (1) Preparation of silane-modified cyclodextrin metal-organic framework material (CD-MOF-2) Preparation route as follows Figure 1 As shown, the specific steps are as follows: γ-cyclodextrin (1.30 g, 1 mmol) and KOH (0.45 g, 8 mmol) were dissolved in H2O (20 mL). The aqueous solution was filtered to allow MeOH (about 50 mL) vapor to diffuse into the solution and kept for one week. The solution was then separated, filtered, and washed with MeOH (2 × 30 mL). After drying in air, CD-MOF-1 was obtained.

[0040] Take 200g of aminopropyltriethoxysilane and prepare 2L of 10wt aminopropyltriethoxysilane aqueous solution (pH 4.0, adjusted with glacial acetic acid). Stir for 1 hour, then add 1kg of CD-MOF-1 and continue stirring for 3 hours. Transfer the solution to a centrifuge tube and centrifuge at 500 rpm for 3 minutes. Remove the supernatant to obtain CD-MOF-2, and wash and dry it repeatedly with ethanol.

[0041] The infrared spectra of the prepared γ-cyclodextrin (i.e., CD), CD-MOF-1 and CD-MOF-2 are as follows: Figure 2 As shown, in CD-MOF-1, 3360 cm -1 Stretching vibrations attributed to -OH; 3301~3356 cm⁻¹ in CD-MOF⁻² -1 The symmetric stretching vibrations belonging to -NH2 and NH stretching vibrations, 1361 cm⁻¹ -1 It belongs to the CN stretching vibration; the thermogravimetric diagrams of the three are as follows: Figure 3 As shown, the weight loss before 100℃ is attributed to the organic solvent in the undried sample. The initial decomposition temperature of CD is around 245℃. The initial decomposition temperature of CD-MOF1 after treatment with potassium hydroxide is reduced to 234℃. The initial decomposition temperature of CD-MOF2 after treatment with aminopropyltriethoxysilane is increased to 288℃. This indicates that the silane-modified cyclodextrin metal-organic framework has thermal stability and fully meets the process temperature requirements of melt extrusion in this invention.

[0042] (2) By mass, the composition of functional layer B is: 1 part CD-MOF-2 and cyclic olefin copolymer (TOPAS@COC9506F-500, melt index 6 cm⁻¹). 3 50 parts of polypropylene (Bormed HD800CF, melt index 8 g / 10 min, 230 °C / 2.16 kg) were mixed evenly; the A and C functional layers were: 50 parts of polypropylene (Bormed HD800CF, melt index 8 g / 10 min, 230 °C / 2.16 kg), 2 parts of maleic anhydride, and 2 parts of azobisisobutyronitrile.

[0043] (3) On the BREYER OptiFlex extrusion line, the masterbatch is fed into the extruder hopper through a dryer. In the plasticizing unit consisting of the extruder's cylinder / screw, the masterbatch is heated and melted, then conveyed to the co-extrusion die. The extrusion temperature of functional layers A and C is 230 °C, and the extrusion temperature of functional layer B is 240 °C. The extrusion gap between layers A and C is 50 μm, and the extrusion gap for the processing melt of layer B is 100 μm. The distance from the co-extrusion die to the calender roll is 1 cm. The melt extruded from the die reaches the calender, where the film is shaped and cooled under controlled temperature on the guide rollers. To induce and control the crystallinity and stress release of the film, two pairs of cooling rollers with progressively decreasing surface temperatures are used. The cooling and shaping rollers have an appropriate temperature to control the crystallinity during the progressive cooling process of the film. Specific parameters are shown in Table 1. A functional plastic film with functional layers A, B, and C arranged sequentially from top to bottom is obtained, such as... Figure 4 As shown.

[0044] Example 2 The B functional layer consists of 5 parts CD-MOF-2 and a cyclic olefin copolymer (TOPAS@COC 9506F-500, melt index 6 cm⁻¹). 3 The following components were mixed evenly: 60 parts of polypropylene (Bormed HD800CF, melt index 8 g / 10 min, 230 °C / 2.16 kg), 2 parts of maleic anhydride, and 2 parts of azobisisobutyronitrile. The preparation method was the same as in Example 1, with differences shown in Table 1.

[0045] Example 3 The B functional layer consists of 10 parts of CD-MOF-2 and a cyclic olefin copolymer (TOPAS@COC 9506F-500, melt index 6 cm⁻¹). 3 The following components were mixed evenly: 70 parts of polypropylene (Bormed HD800CF, melt index 8 g / 10 min, 230 °C / 2.16 kg), 2 parts of maleic anhydride, and 2 parts of azobisisobutyronitrile. The preparation method was the same as in Example 1, with differences shown in Table 1.

[0046] Example 4 The B functional layer consists of 15 parts of CD-MOF-2 and a cyclic olefin copolymer (TOPAS@COC 9506F-500, melt index 6 cm⁻¹). 3The following components were mixed evenly: 80 parts of polypropylene (Bormed HD800CF, melt index 8 g / 10 min, 230 °C / 2.16 kg), 2 parts of maleic anhydride, and 2 parts of azobisisobutyronitrile. The preparation method was the same as in Example 1, with differences shown in Table 1.

[0047] Example 5 The B functional layer consists of 20 parts of CD-MOF-2 and a cyclic olefin copolymer (TOPAS@COC 9506F-500, melt index 6 cm⁻¹). 3 The following components were mixed evenly: 90 parts of polypropylene (Bormed HD800CF, melt index 8 g / 10 min, 230 °C / 2.16 kg), 2 parts of maleic anhydride, and 2 parts of azobisisobutyronitrile. The preparation method was the same as in Example 1, with differences shown in Table 1.

[0048] Example 6 The B functional layer consists of 25 parts of CD-MOF-2 and a cyclic olefin copolymer (TOPAS@COC 9506F-500, melt index 6 cm⁻¹). 3 The following components were mixed evenly: 50 parts of polypropylene (Bormed HD800CF, melt index 8 g / 10 min, 230 °C / 2.16 kg), 2 parts of maleic anhydride, and 2 parts of azobisisobutyronitrile. The preparation method was the same as in Example 1, with differences shown in Table 1.

[0049] Example 7 The B functional layer consists of 5 parts of CD-MOF-2 and a cyclic olefin copolymer (TOPAS@9506F-500, melt index 6 cm⁻¹). 3 The following components were mixed thoroughly: 70 parts of polypropylene (Bormed TD109CF, melt index 6 g / 10 min, 230 °C / 2.16 kg), 10 parts of maleic anhydride, and 6 parts of azobisisobutyronitrile (AIBN). The preparation method was the same as in Example 1, with differences shown in Table 1.

[0050] Example 8 The B functional layer consists of 10 parts of CD-MOF-2 and a cyclic olefin copolymer (TOPAS@7010F-600, melt index 11 cm⁻¹). 3The following mixture was prepared: 80 parts of polypropylene (Bormed RD804CF, melt index 8 g / 10 min, 230 °C / 2.16 kg), mixed thoroughly; the A and C functional layers were: 80 parts of polypropylene (Bormed RD804CF, melt index 8 g / 10 min, 230 °C / 2.16 kg), 15 parts of maleic anhydride, and 6 parts of azobisisobutyronitrile. The preparation method was the same as in Example 1, with differences shown in Table 1.

[0051] Comparative Example 1 The preparation method is the same as in Example 1, except that CD-MOF-2 is not added to the B functional layer. Otherwise, it is consistent with Example 1.

[0052] Comparative Example 2 The preparation method is the same as in Example 1, except that COC and 5 parts of CaCl2 are added to the B functional layer, while the rest is the same as in Example 1.

[0053] Sample Analysis Water vapor permeability was measured using ASTM E96 Standard Test Methods for Water Vapor Transmission of Materials at 23°C and 90% relative humidity. Oxygen permeability test conditions GB / T 1038–2000: 23℃, 50% relative humidity.

[0054] Table 1: Preparation parameters and test results of the examples and comparative examples

[0055] Note: WVTR: Water vapor permeation test conditions, RH 90%, 38 ℃; OTR: Oxygen permeation test conditions, RH 50%, 23 ℃.

[0056] As can be seen from Table 1, when the extrusion layer thickness is in the range of 200~700 μm and the extrusion temperature is in the range of 180~220℃, the functional plastic prepared by this invention has good water and oxygen barrier properties, excellent mechanical properties, and no exudates. CD-MOF-1, while maintaining the internal pore function of MOF, is modified by 3-aminopropyltriethoxysilane (APTES) to change its external surface chemical properties, resulting in low-polarity CD-MOF-2, which in turn increases its interfacial compatibility with COC. The -NH2 in CD-MOF-2 crosslinks with maleic anhydride in functional layers A and C, and maleic anhydride is also crosslinked and grafted with polypropylene, thus playing a role in bonding the three functional layers A, B, and C. Furthermore, the CD-MOF-2 involved in crosslinking also plays a role in active moisture absorption without exudation.

[0057] In Comparative Example 1, the B functional layer lacked CD-MOF-2, resulting in a blister material with poor water and oxygen permeability. Additionally, the interlayer adhesion between PP and COC was weak.

[0058] In Comparative Example 2, the functional layer B consists of COC and calcium chloride particles, resulting in a bubble material with poor water and oxygen permeability, and also contains calcium chloride precipitates.

[0059] The above description is merely a preferred embodiment of the present invention and is not intended to limit the present invention. Although the present invention has been described in detail with reference to the foregoing embodiments, those skilled in the art can still modify the technical solutions described in the foregoing embodiments or make equivalent substitutions for some of the technical features. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present invention should be included within the protection scope of the present invention.

Claims

1. A three-layer co-extruded film for pharmaceutical blister, characterized in that, It includes functional layers A, B, and C. Functional layer B contains cyclic olefin copolymers and silane-modified cyclodextrin metal-organic framework materials, while functional layers A and C each contain polypropylene and maleic anhydride.

2. The three-layer co-extruded film for pharmaceutical blister according to claim 1, characterized in that, The silane-modified cyclodextrin metal-organic framework material is obtained by sequentially modifying γ-cyclodextrin with potassium hydroxide, methanol, and aminopropyltriethoxysilane, and has the structure shown in formula (I): Equation (Ⅰ).

3. The three-layer co-extruded film for pharmaceutical blister packs according to claim 1, characterized in that, In the B functional layer, the mass ratio of the cyclic olefin copolymer to the silane-modified cyclodextrin metal-organic framework material is 50~90:1~25.

4. The three-layer co-extruded film for pharmaceutical blister packs according to claim 1, characterized in that, The melt index of the cyclic olefin copolymer is 6 to 12 cm 3 / 10 min.

5. The three-layer co-extruded film for pharmaceutical blister packs according to claim 1, characterized in that, The A and C functional layers also contain azobisisobutyronitrile, and the mass ratio of polypropylene, maleic anhydride and azobisisobutyronitrile is 50~90:2~20:2~8.

6. The three-layer co-extruded film for pharmaceutical blister packs according to claim 5, characterized in that, The melt index of the polypropylene is 6~8 g / 10min.

7. The three-layer co-extruded film for pharmaceutical blister packs according to claim 1, characterized in that, The total thickness of the three-layer co-extruded film for pharmaceutical blister packs is 200~700 μm, wherein the thickness of functional layers A and C is 50~100 μm, and the thickness of functional layer B is 100~500 μm.

8. The method for preparing a three-layer co-extruded film for pharmaceutical blister packs according to any one of claims 1 to 7, characterized in that, Includes the following steps: (1) Prepare silane-modified cyclodextrin metal-organic framework material, add cycloolefin copolymer, mix evenly, and obtain B functional layer masterbatch; (2) Polypropylene, maleic anhydride and azobisisobutyronitrile are mixed to prepare A functional layer masterbatch and C functional layer masterbatch. (3) Following the order of functional layer A, functional layer B, and functional layer C, the masterbatch obtained in steps (1) and (2) is processed by a three-layer melt co-extrusion molding method to obtain a three-layer co-extruded film for pharmaceutical blister packs.

9. The application of the three-layer co-extruded film for pharmaceutical blister packs according to any one of claims 1 to 7 in the preparation of pharmaceutical blister packs.